Lucid Diagnostics Inc. Operating Cash Flow
Lucid Diagnostics Inc. (LUCD) reported Operating Cash Flow of -$23.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$11.30M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$12.10M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$12.58M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$10.89M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$46.48M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$44.14M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$32.82M.
- Lucid Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$29.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$23.40M 10-Q · filed 2026-08-12 | -$35.98M derived: sum of 3 quarters · filed 2026-08-12 | -$46.87M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$12.10M 10-Q · filed 2026-05-13 | -$24.68M derived: sum of 2 quarters · filed 2026-05-13 | -$35.57M derived: sum of 3 quarters · filed 2026-05-13 | -$46.12M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$23.47M derived: sum of 2 quarters · filed 2026-03-25 | -$34.02M derived: sum of 3 quarters · filed 2026-08-12 | -$46.48M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | -$10.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$21.44M derived: sum of 2 quarters · filed 2026-08-12 | -$33.91M 10-Q · filed 2025-11-12 | -$43.78M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$10.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$23.01M 10-Q · filed 2026-08-12 | -$32.88M derived: sum of 3 quarters · filed 2026-08-12 | -$43.06M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$12.46M 10-Q · filed 2026-05-13 | -$22.34M derived: sum of 2 quarters · filed 2026-05-13 | -$32.51M derived: sum of 3 quarters · filed 2026-05-13 | -$43.99M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$9.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$20.05M derived: sum of 2 quarters · filed 2026-03-25 | -$31.53M derived: sum of 3 quarters · filed 2026-03-25 | -$44.14M 10-K · filed 2026-03-25 | ||
| 2024-09-30 | -$10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$21.66M derived: sum of 2 quarters · filed 2025-11-12 | -$34.27M 10-Q · filed 2025-11-12 | -$44.25M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$11.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$24.09M 10-Q · filed 2025-08-12 | -$34.07M derived: sum of 3 quarters · filed 2025-08-12 | -$42.85M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$12.61M 10-Q · filed 2025-05-13 | -$22.59M derived: sum of 2 quarters · filed 2025-05-13 | -$31.37M derived: sum of 3 quarters · filed 2025-05-13 | -$38.31M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$18.76M derived: sum of 2 quarters · filed 2025-03-24 | -$25.70M derived: sum of 3 quarters · filed 2025-03-24 | -$32.82M 10-K · filed 2025-03-24 | ||
| 2023-09-30 | -$8.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$15.72M derived: sum of 2 quarters · filed 2024-11-12 | -$22.84M 10-Q · filed 2024-11-12 | -$27.10M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$14.06M 10-Q · filed 2024-08-12 | -$18.32M derived: sum of 3 quarters · filed 2024-08-12 | -$24.66M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$7.12M 10-Q · filed 2024-05-13 | -$7.04M 10-Q · filed 2023-05-15 | -$11.38M derived: sum of 2 quarters · filed 2024-05-13 | -$17.72M derived: sum of 3 quarters · filed 2024-05-13 | -$31.03M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$10.60M derived: sum of 2 quarters · filed 2024-03-25 | -$23.91M derived: sum of 3 quarters · filed 2024-03-25 | -$29.68M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | -$6.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$19.65M derived: sum of 2 quarters · filed 2023-11-13 | -$25.43M 10-Q · filed 2023-11-13 | -$35.30M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$19.08M 10-Q · filed 2023-08-14 | -$28.96M derived: sum of 3 quarters · filed 2023-08-14 | -$31.14M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$5.78M 10-Q · filed 2023-05-15 | -$15.65M derived: sum of 2 quarters · filed 2023-05-15 | -$17.84M derived: sum of 3 quarters · filed 2023-05-15 | -$20.13M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$9.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$12.06M derived: sum of 2 quarters · filed 2023-03-14 | -$14.35M derived: sum of 3 quarters · filed 2023-03-14 | -$17.67M 10-K · filed 2023-03-14 | ||
| 2021-09-30 | -$2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$4.48M derived: sum of 2 quarters · filed 2022-11-14 | -$7.79M 10-Q · filed 2022-11-14 | -$7.79M 10-Q · filed 2021-11-23 | -$9.47M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$5.61M 10-Q · filed 2022-08-15 | -$7.28M derived: sum of 3 quarters · filed 2022-08-15 | |||
| 2021-03-31 | -$3.31M 10-Q · filed 2022-05-16 | -$4.99M derived: sum of 2 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | -$5.63M 10-K · filed 2022-04-06 | ||||
| 2020-09-30 | -$3.95M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |